Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,228 | -$1,749 | -$1,590 | -$1,617 |
| Dep. & Amort. | $26 | $26 | $25 | $43 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $404 | $177 | $67 | $81 |
| Change in WC | $77 | $107 | -$872 | -$24 |
| Other Non-Cash | -$45 | -$312 | $39 | $0 |
| Operating Cash Flow | -$1,721 | -$1,751 | -$2,333 | -$1,517 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $23 | -$23 | $0 |
| Stock Issued | $244 | $396 | $14,579 | $2,072 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$202 | $217 | $0 |
| Financing Cash Flow | $244 | $217 | $14,773 | $2,072 |
| Forex Effect | -$48 | -$1 | $110 | -$28 |
| Net Chg. in Cash | -$1,570 | -$1,535 | $12,333 | $526 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,362 | $13,897 | $1,564 | $1,037 |
| End Cash | $10,792 | $12,362 | $13,897 | $1,564 |
| Free Cash Flow | -$1,721 | -$1,751 | -$2,333 | -$1,517 |